<SEC-DOCUMENT>0001819790-21-000059-index.html : 20211203
<SEC-HEADER>0001819790-21-000059.hdr.sgml : 20211203
<ACCEPTANCE-DATETIME>20211203185658
ACCESSION NUMBER:		0001819790-21-000059
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20211201
FILED AS OF DATE:		20211203
DATE AS OF CHANGE:		20211203

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ackermann Michael
		CENTRAL INDEX KEY:			0001791249

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39614
		FILM NUMBER:		211471530

	MAIL ADDRESS:	
		STREET 1:		202 CARNEGIE CENTER
		STREET 2:		SUITE 109
		CITY:			PRINCETON
		STATE:			NJ
		ZIP:			08540

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tarsus Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001819790
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				814717861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		15440 LAGUNA CANYON ROAD
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
		BUSINESS PHONE:		(949) 409-9820

	MAIL ADDRESS:	
		STREET 1:		15440 LAGUNA CANYON ROAD
		CITY:			IRVINE
		STATE:			CA
		ZIP:			92618
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wf-form4_163857580594057.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wf-form4_163857580594057.html

Document 1 - RAW XML: wf-form4_163857580594057.xml

</DOCUMENT>
</SEC-DOCUMENT>